Trident Peptides presents high-quality Tirzepatide (LY3298176), a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This trident peptides compound demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.
Our trident peptides formulation of Tirzepatide exhibits enhanced affinity for GIP receptors while maintaining significant GLP-1 receptor activity. This unique dual agonist profile makes it particularly valuable for metabolic research applications. The compound has shown promising results in improving glycemic control in preclinical studies.
The trident peptides Tirzepatide is supplied as a white powder with exceptional purity (>98%), carefully manufactured under strict quality control standards. Each batch undergoes rigorous HPLC testing to ensure consistent quality and performance in research settings.
For research purposes only. Not for human consumption. This trident peptides product is intended solely for laboratory research by qualified professionals.